The main events of 2019 at the Federal State Budgetary Institution “NMIC of Radiology” of the Ministry of Health of Russia

FSBI “NMIC of Radiology” of the Ministry of Health of Russia is the first scientific medical cluster in Russia in the field of oncology, radiology and urology. Today, the Center has three branches: the P.A. Hertsen Moscow Research Oncological Institute, the A.F. Tsyba Medical Radiological Research Center, and the N.A. Lopatkin Research Institute of Urology and Interventional Radiology.

Thanks to the merger of three leading Russian research institutes, the FSBI “NMIC of Radiology” of the Ministry of Health of Russia has been tasked with becoming one of the world leaders in nuclear medicine.

The status of the National Center has significantly expanded the opportunities for patients to receive all aspects of modern high-tech medical care: from surgery using photodynamic therapy and intraoperative chemotherapy to radiation therapy and radiosurgery. Every year, the Center launches new methods and technologies for the treatment of patients.

In 2019, on the basis of the A.F. Tsyba MRSC, a branch of the FSBI “NMIC of Radiology” of the Ministry of Health of the Russian Federation, the first Russian operation on radioembolization of the liver with domestic radio sources took place. The use of this highly effective method makes it possible to stop tumor growth in almost 90% of patients and increases life expectancy by 4-5 times compared to other standard methods of treatment. For the FSBI “NMIC of Radiology” of the Ministry of Health of the Russian Federation, this has become one of the strategic directions within the framework of the program for the development of modern types of oncological care in Russia.

In November 2019, on the basis of the A.F. Tsyba MRSC, a branch of the FSBI “NMIC of Radiology” of the Ministry of Health of the Russian Federation, with the participation of specialists from Israel, Germany and the USA, in accordance with an international protocol, the world’s first brachytherapy operation on the mammary gland in advanced cancer using alpha particles with the ability not only to destroy the tumor was performed, but also to stimulate the process of strengthening the immune system, which begins to fight metastases itself.

In 2019, the N.A. Lopatkin Research Institute of Urology and Interventional Radiology – a branch of the Federal State Budgetary Institution “NMIC of Radiology” of the Ministry of Health of Russia celebrated its 40th anniversary. In many respects, thanks to the efforts of the Ministry of Health of the Russian Federation and personally Minister V.I. Modern laboratories equipped with the latest generation of equipment for clinical diagnostic and molecular genetic studies, an MRI room and a department of urodynamics that has no analogues in Europe, a new 50-bed department, a children’s department, intensive care wards and new ultramodern operating rooms were put into operation at the center, and what is very important, it was launched in the updated Hemodialysis Center works with the connection of 20 artificial kidney devices, allowing 2000 procedures per month.

The Center has a high scientific potential. Within its walls, a whole galaxy of scientists has been brought up who are engaged in fundamental developments and their application in practice, the creation of new antitumor drugs in the treatment of oncological diseases, experimental research and clinical trials of the latest drugs are conducted. So, in 2019, in order to develop additive technologies, a modern 3D bioprinter for printing and cultivating three-dimensional cellular structures was purchased and installed at the FSBI “NMIC of Radiology” of the Ministry of Health of the Russian Federation. Tests are being conducted at the moment.

December 10 at the P. Hertsen Moscow Oncology Research Institute – a branch of the Federal State Budgetary Institution “NMIC of Radiology” of the Ministry of Health of Russia, together with the laboratory”3D Bioprinting Solution” (Invitro company) has completed a set of preclinical tests for the regeneration of the skin of experimental rats by 3D bioprinting by a robot hand (Cook Company, Germany) right in the operating room. The regenerating gel was developed by scientists of the Hertsen Institute from the cells of the patient himself, which removes the problem of implant rejection.

The Center actively cooperates with the Russian Academy of Sciences (RAS) and other Russian and foreign research institutes, corporations, scientific and industrial associations. In 2019 alone, the Federal State Budgetary Institution “NMIC of Radiology” of the Ministry of Health of Russia signed 14 agreements on cooperation and development of scientific and clinical potential. It is particularly worth noting the signing in September 2019 of a Russian-Japanese memorandum on the creation of the first ion therapy center in Russia. A center for the treatment of oncological diseases with heavy carbon ions will be built in Obninsk.

In 2019, a new international telemedicine project was launched jointly with leading medical centers in Tokyo and Osaka (Japan). It is based on the creation of a telepathological platform based on the Center, thanks to which telemedicine consultations will be held in the format of a “second opinion”, the exchange of scientific data, and joint research will be conducted.

In April 2019, a landmark event took place at the A.F. Tsyba MRSC – for the first time under the auspices of two national medical centers: NMIC of Radiology of the Ministry of Health of Russia and NMIC of Hematology of the Ministry of Health of Russia with the direct participation of the General

The first meeting of the directors of Academician A.D. Kaprin and Academician V.G. Savchenko was held

joint scientific and practical conference “Paradigms of drug therapy in

cancer patients”. For the first time in Russia, leading experts in the field of hematology of drug therapy of cancer discussed the problems and prospects of drug therapy of cancer patients.

In June 2019, an agreement on cooperation between Russia and the Republic of Bulgaria was signed in the field of organizing the treatment of patients from the Republic of Belarus using proton therapy, which opens a new page in the implementation of the national medical tourism program.

Another landmark event of the year was the signing of the Russian-Kazakh agreement on the teleconsultation of glass products and the provision of the “second opinion” service by the specialists of the Center.

In September 2019, as part of the Second International Forum on Oncology and Radiology, an agreement was signed with a member of the Association of Directors of Oncological and Radiological Institutes of the CIS and Eurasia (ADIOR) – The Uzbek Oncology Center, as well as with the State Oncological Institute of Serbia on cooperation in the field of education and exchange of experience in the development of diagnostics and treatment of oncological diseases.

In 2019, on the initiative of the Center, the First International Congress on rare tumors was held, which brought together more than 800 Russian and foreign specialists on one site to discuss modern scientific achievements, the latest medical experience and technologies in the field of diagnosis and treatment of orphan diseases, as well as the development of effective solutions and recommendations for specialized specialists, including primary care, on the effective diagnosis and treatment of this type of diseases.

In November 2019, an unprecedented event took place in Berlin, the Russian-German session “Nuclear Medicine – the Alchemy of modern Oncology”, which brought together the world’s leading experts on one platform. It is noteworthy that for the first time Russian scientists initiated such an event within the framework of the Berlin Science Week, presenting their own developments and technologies in the field of nuclear medicine.

On the initiative of the Center and with the support of the Federation Council of the Federal Assembly of the Russian Federation, the Ministry of Health of Russia, the Association of Oncologists of Russia, an unprecedented educational all-Russian project “Oncopatrul” was launched in 2019. The project is aimed at promoting a healthy lifestyle and the formation of cancer awareness among citizens of the Russian Federation. The uniqueness of the project lies in the fact that oncologists of the Federal State Budgetary Institution “NMIC of Radiology” of the Ministry of Health of the Russian Federation, together with regional oncological dispensaries, conduct screening under the men’s and women’s health program at the largest city–forming enterprises in the constituent entities of the Russian Federation. Employees of enterprises “before” or “after” the work shift have the opportunity to check their health. At the moment, 7 subjects of the Russian Federation have participated in the project: Moscow, Yaroslavl, Moscow, Voronezh, Kursk, Samara regions and the Republic of Bashkortostan. 1878 people were examined and 16 oncological cases were detected, 124 people had pathologies of various localizations.

Press Service of the Federal State Budgetary Institution “NMIC of Radiology” of the Ministry of Health of Russia